TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31422713

Group type: EXPERIMENTAL
Intervention: Vortioxetine 10/20 mg
Number of subjects: 529

Group type: COMPARATOR
Intervention: Duloxetine 60 mg
Number of subjects: 529

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 529
Study: 29689081

Group type: EXPERIMENTAL
Intervention: 15-hour mindfulness course over seven weeks with booster sessions twice yearly
Number of subjects: 288

Group type: COMPARATOR
Intervention: Normal study curricula
Number of subjects: 288
Study: 26945156

Group type: EXPERIMENTAL
Intervention: CHF6001 (inhaled PDE4 inhibitor)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Multiple ascending doses of CHF6001
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pharmacokinetic/pharmacodynamic analysis of CHF6001
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 100
Study: 26461847

Group type: EXPERIMENTAL
Intervention: Neoadjuvant combined androgen blockade (CAB) for ≥ 6 months
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Neoadjuvant combined androgen blockade (CAB) for ≥ 6 months in patients with intermediate-risk prostate cancer with D90 < 180 Gy
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Neoadjuvant combined androgen blockade (CAB) and D90
Number of subjects: 431
Study: 23354148

Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation program
Number of subjects: 61
Study: 21539629

Group type: EXPERIMENTAL
Intervention: Aquatic exercises
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Land-based exercises
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 84
Study: 18308095

Group type: EXPERIMENTAL
Intervention: Bipolar transurethral resection of the prostate (TURP) using the Gyrus PlasmaKinetic System (PK group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Monopolar TURP (standard TURP group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both PK and standard TURP groups
Number of subjects: 120
Study: 16549129

Group type: EXPERIMENTAL
Intervention: 0.5 mg morphine + 10 mg ropivacaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.3 mg morphine + 10 mg ropivacaine
Number of subjects: 30
Study: 14618032

Group type: EXPERIMENTAL
Intervention: Rate control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rhythm control
Number of subjects: 0
Study: 11092465

Group type: EXPERIMENTAL
Intervention: Lenograstim 150 microg/m2/d
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Lenograstim 100 microg/m2/d
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Lenograstim 50 microg/m2/d
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Lenograstim 25 microg/m2/d
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Lenograstim (all doses)
Number of subjects: 69
Study: 7796592

Group type: EXPERIMENTAL
Intervention: Progesterone-releasing vaginal ring (5 mg/24 h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Progesterone-releasing vaginal ring (20 mg/24 h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both rings
Number of subjects: 20
Study: 2370671

Group type: EXPERIMENTAL
Intervention: yohimbine
Number of subjects: 40

Group type: COMPARATOR
Intervention: yohimbine and placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: neither
Number of subjects: 40
Study: 647693

Group type: EXPERIMENTAL
Intervention: High-dose tamoxifen
Number of subjects: 4
Study: 30060027

Group type: EXPERIMENTAL
Intervention: Lopinavir monotherapy
Number of subjects: 386
Study: 29051501

Group type: EXPERIMENTAL
Intervention: Genetically predicted one standard deviation higher isoleucine levels
Number of subjects: 17562

Group type: COMPARATOR
Intervention: Leucine- and valine-raising allele
Number of subjects: 17562
Study: 26386894

Group type: EXPERIMENTAL
Intervention: Manual Diaphragm Release Technique
Number of subjects: 20
Study: 23644384

Group type: EXPERIMENTAL
Intervention: Low-dose fentanyl plus placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High-dose fentanyl plus placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-dose fentanyl plus dexmedetomidine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fast tracking success rates
Number of subjects: 48
Study: 21647901

Group type: EXPERIMENTAL
Intervention: Skills training using the model
Number of subjects: 20

Group type: COMPARATOR
Intervention: Didactic instruction
Number of subjects: 20
Study: 20128318

Group type: EXPERIMENTAL
Intervention: Sensodyne Extra Whitening
Number of subjects: 295

Group type: COMPARATOR
Intervention: Crest Maximum Strength Sensitivity Protection Whitening plus Scope
Number of subjects: 295

Group type: COMPARATOR
Intervention: Colgate Tartar Control Plus Whitening Mint
Number of subjects: 295
Study: 16881943

Group type: EXPERIMENTAL
Intervention: < or = 6th grade literacy
Number of subjects: 235

Group type: COMPARATOR
Intervention: > or = 9th grade literacy
Number of subjects: 235
Study: 15266131

Group type: EXPERIMENTAL
Intervention: Ear mushrooms alone
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ear mushrooms with additives
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 11699405

Group type: EXPERIMENTAL
Intervention: ACOP+ (cyclophosphamide, doxorubicin, vincristine, 6-mercaptopurine, and prednisone)
Number of subjects: 120

Group type: COMPARATOR
Intervention: APO (doxorubicin, vincristine, 6-mercaptopurine, and prednisone)
Number of subjects: 120
Study: 9329417

Group type: EXPERIMENTAL
Intervention: Chicken-based diet
Number of subjects: 56

Group type: COMPARATOR
Intervention: Vivonex (elemental diet)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Nursoy (soy diet)
Number of subjects: 56
Study: 8281674

Group type: EXPERIMENTAL
Intervention: Fosinopril 40 mg daily for 6 months
Number of subjects: 509

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509
Study: 3353076

Group type: EXPERIMENTAL
Intervention: methylprednisolone plus alizapride (800 mg i.v. total dose)
Number of subjects: 52

Group type: COMPARATOR
Intervention: methylprednisolone (1 g i.v. total dose)
Number of subjects: 52
Study: 31770574

Group type: EXPERIMENTAL
Intervention: Shenfu injection (SFI) in combination with epinephrine
Number of subjects: 1233

Group type: COMPARATOR
Intervention: Standard treatment with epinephrine alone
Number of subjects: 1233
Study: 30477940

Group type: EXPERIMENTAL
Intervention: Endovascular aneurysm repair (EVAR)
Number of subjects: 201
Study: 28441266

Group type: EXPERIMENTAL
Intervention: IXIARO
Number of subjects: 1869

Group type: COMPARATOR
Intervention: Prevnar
Number of subjects: 1869

Group type: COMPARATOR
Intervention: HAVRIX
Number of subjects: 1869
Study: 25980483

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics (olanzapine 10-20 mg or risperidone 4-8 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Typical antipsychotics
Number of subjects: 30
Study: 22718435

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg twice daily + Rifampin 300 mg daily
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg twice daily + Placebo-Rifampin daily
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Rifampin 300 mg daily + Placebo-Doxycycline twice daily
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo-Doxycycline twice daily + Placebo-Rifampin daily
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Doxycycline or Rifampin (alone or in combination)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Secondary outcomes (SMMSE, Quick mild cognitive impairment screen, Geriatric Depression Scale, Cornell Scale for Depression in Dementia, Lawton Scale, Dysfunctional Behavior Rating Instrument)
Number of subjects: 406
Study: 21259251

Group type: EXPERIMENTAL
Intervention: Modified parotidectomy technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional parotidectomy technique
Number of subjects: 0
Study: 19399969

Group type: EXPERIMENTAL
Intervention: Protocolized weaning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-protocolized practice
Number of subjects: 0
Study: 16540931

Group type: EXPERIMENTAL
Intervention: 20 mg oxandrolone
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: 40 mg oxandrolone
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: 80 mg oxandrolone
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study: 12640407

Group type: EXPERIMENTAL
Intervention: 0.75% levobupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.75% bupivacaine
Number of subjects: 60
Study: 10730731

Group type: EXPERIMENTAL
Intervention: 50 mg diclofenac p.o. premedication
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo premedication
Number of subjects: 200
Study: 9187292

Group type: EXPERIMENTAL
Intervention: Modified Card Sorting Test (MCST)
Number of subjects: 0
Study: 1403175

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 3977547

Group type: EXPERIMENTAL
Intervention: Apomorphine hydrochloride
Number of subjects: 57

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Dopamine hydrochloride
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Levodopa‐carbidopa (Sinemet)
Number of subjects: 57
Study: 30959858

Group type: EXPERIMENTAL
Intervention: Smartphone Med Adherence Stops Hypertension (SMASH)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Enhanced Standard Care (ESC)
Number of subjects: 54
Study: 30268627

Group type: EXPERIMENTAL
Intervention: High plane of milk (10 L/d)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low plane of milk (5 L/d)
Number of subjects: 26
Study: 25129282

Group type: EXPERIMENTAL
Intervention: Aerobic Continuous Training (ACT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training (AIT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both ACT and AIT pooled together
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both ACT and AIT
Number of subjects: 20
Study: 21390413

Group type: EXPERIMENTAL
Intervention: Rapid Influenza Diagnostic Test (RIDT)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: ILI clinical data
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: ILI clinical data and RIDT together
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Use of RIDT
Number of subjects: 78
Study: 19517600

Group type: EXPERIMENTAL
Intervention: Essential oils exposure; details on dosage and duration not specified.
Number of subjects: 0
Study: 17404515

Group type: EXPERIMENTAL
Intervention: New DTPw-HBV vaccine
Number of subjects: 239

Group type: COMPARATOR
Intervention: Licensed DTPw and HBV vaccines (given separately)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Licensed DTPw-HBV combination (Tritanrix-HepB)
Number of subjects: 239
Study: 15205563

Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg daily for 3 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bromocriptine vs Placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bromocriptine and Placebo
Number of subjects: 40
Study: 11701294

Group type: EXPERIMENTAL
Intervention: Pneumococcal and influenza immunization reminder letter (Group 3)
Number of subjects: 6600

Group type: COMPARATOR
Intervention: Influenza immunization reminder letter only (Group 2)
Number of subjects: 6600

Group type: COMPARATOR
Intervention: No letter (Group 1)
Number of subjects: 6600
Study: 9032191

Group type: EXPERIMENTAL
Intervention: Aerosolized alpha1-protease inhibitor (200 mg)
Number of subjects: 29
Study: 8485017

Group type: EXPERIMENTAL
Intervention: Amiloride (5 and 20 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Spironolactone (25 and 100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (100 mg)
Number of subjects: 12
Study: 3111784

Group type: EXPERIMENTAL
Intervention: NORPLANT implants
Number of subjects: 283

Group type: COMPARATOR
Intervention: Two covered rods
Number of subjects: 283
Study: 32609

Group type: EXPERIMENTAL
Intervention: Benorylate
Number of subjects: 85

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 85
Study: 31856379

Group type: EXPERIMENTAL
Intervention: Pecan nut group (PNG) - healthy diet plus 30 g day-1 of pecan nuts
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control group (CG) - healthy diet according to nutritional guidelines
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Olive oil group (OOG) - healthy diet plus 30 mL day-1 of extra-virgin olive oil
Number of subjects: 204
Study: 31135272

Group type: EXPERIMENTAL
Intervention: Second person self-talk
Number of subjects: 16

Group type: COMPARATOR
Intervention: First person self-talk
Number of subjects: 16
Study: 28948836

Group type: EXPERIMENTAL
Intervention: Ethics consultation simulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional didactic format
Number of subjects: 0
Study: 26175260

Group type: EXPERIMENTAL
Intervention: Lifestyle Advice
Number of subjects: 1582

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 1582
Study: 22885142

Group type: EXPERIMENTAL
Intervention: Biphasic pulses delivered in an anterioposterior direction (posteriorly directed)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Biphasic pulses directed posteroanterior (anteriorly)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Monophasic pulses from either direction
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1 Hz study with posteriorly directed biphasic pulses
Number of subjects: 8
Study: 20561179

Group type: EXPERIMENTAL
Intervention: GSM 900 exposure
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: WCDMA exposure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 30
Study: 19732949

Group type: EXPERIMENTAL
Intervention: Full screening of windows, doors, and closing eaves
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Screened ceilings
Number of subjects: 755

Group type: COMPARATOR
Intervention: No screening (control)
Number of subjects: 755
Study: 24683680

Group type: EXPERIMENTAL
Intervention: Biofortified rice substitution for habitual rice consumption
Number of subjects: 300

Group type: COMPARATOR
Intervention: Habitual diet without biofortified rice
Number of subjects: 300
Study: 15279528

Group type: EXPERIMENTAL
Intervention: Exposure only (EO)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Exposure with phobic safety-behavior availability (SBA)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Exposure with safety-behavior utilization (SBU)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Credible placebo treatment (PL)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Wait list (WL)
Number of subjects: 72
Study: 11515715

Group type: EXPERIMENTAL
Intervention: Crataegus extract WS 1442 (3 x 1 capsule)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9571266

Group type: EXPERIMENTAL
Intervention: RGP contact lenses
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Flexible gas permeable lenses
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Soft contact lenses
Number of subjects: 13

Group type: COMPARATOR
Intervention: Spectacle correction
Number of subjects: 13
Study: 7938794

Group type: EXPERIMENTAL
Intervention: Postural drainage combined with forced expiratory technique (PD+FET)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Positive expiratory pressure breathing combined with forced expiratory technique (PEP+FET)
Number of subjects: 14
Study: 2967477

Group type: EXPERIMENTAL
Intervention: Prednisone 30 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Prednisolone methylsulfobenzoate 30 mg
Number of subjects: 6
Study: 31841279

Group type: EXPERIMENTAL
Intervention: Central blood pressure (BP) measurement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Central BP strategy for confirming a diagnosis of hypertension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guidance of hypertension management with central BP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Central BP-guided therapeutic strategies
Number of subjects: 0
Study: 29602646

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (cohort A)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nivolumab (cohort B)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nivolumab (cohort C)
Number of subjects: 79
Study: 28293063

Group type: EXPERIMENTAL
Intervention: Bevacizumab added to standard chemotherapy
Number of subjects: 207

Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 207
Study: 26887366

Group type: EXPERIMENTAL
Intervention: Minocycline quadruple therapy
Number of subjects: 135

Group type: COMPARATOR
Intervention: Tailored therapy
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 135
Study: 24285457

Group type: EXPERIMENTAL
Intervention: 4% urea lotion
Number of subjects: 41

Group type: COMPARATOR
Intervention: Liquid petrolatum
Number of subjects: 41
Study: 21569813

Group type: EXPERIMENTAL
Intervention: Solicited self-reporting
Number of subjects: 2675

Group type: COMPARATOR
Intervention: Unsolicited self-reporting
Number of subjects: 2675
Study: 18468269

Group type: EXPERIMENTAL
Intervention: Dry-needling
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.25% lidocaine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.25% lidocaine associated with corticoid
Number of subjects: 45
Study: 17077202

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15555719

Group type: EXPERIMENTAL
Intervention: Milnacipran (100 mg/day)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Paroxetine (20 mg/day)
Number of subjects: 300
Study: 11371420

Group type: EXPERIMENTAL
Intervention: Sputum induction
Number of subjects: 79
Study: 9226144

Group type: EXPERIMENTAL
Intervention: Conjoint analysis for assessing preferences
Number of subjects: 0
Study: 8217301

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy plus operation
Number of subjects: 260

Group type: COMPARATOR
Intervention: Operation alone
Number of subjects: 260
Study: 2967186

Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg day‐1
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Bisoprolol 10 mg day‐1
Number of subjects: 315

Group type: COMPARATOR
Intervention: Atenolol 50 mg day‐1
Number of subjects: 315
Study: 29682796

Group type: EXPERIMENTAL
Intervention: JNJ‐39758979 300 mg once daily for 12 weeks
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 26836415

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Attention bias modification control treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Socially anxious participants (compared to healthy controls)
Number of subjects: 26
Study: 25335376

Group type: EXPERIMENTAL
Intervention: 5‐Fluorouracil (5‐FU) plus CAG
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mitomycin C (MMC) plus CAG
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pterygium size
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pterygium morphology
Number of subjects: 80
Study: 23511558

Group type: EXPERIMENTAL
Intervention: Trial participation (RCT acceptance)
Number of subjects: 486

Group type: COMPARATOR
Intervention: Trial decliners
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Reasons for trial acceptance
Number of subjects: 486

Group type: COMPARATOR
Intervention: Reasons for trial declining
Number of subjects: 486

Group type: COMPARATOR
Intervention: Preference for treatment decision
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Perception of doctors' attitudes towards trial participation
Number of subjects: 486
Study: 20307227

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study: 25159906

Group type: EXPERIMENTAL
Intervention: Condom use promotion leaflet with quiz and prize draw
Number of subjects: 404

Group type: COMPARATOR
Intervention: Control condition (no leaflet or incentive)
Number of subjects: 404
Study: 16507967

Group type: EXPERIMENTAL
Intervention: Supportive counselling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 12567169

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 209

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 209
Study: 11334233

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0
Study: 8851527

Group type: EXPERIMENTAL
Intervention: Exercise intensity at 73W (Ex-1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exercise intensity at 103W (Ex-2)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exercise intensity at 133W (Ex-3)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 6
Study: 1729617

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.25 micrograms twice a day)
Number of subjects: 622

Group type: COMPARATOR
Intervention: Calcium (1 g of elemental calcium daily)
Number of subjects: 622
Study: 6390463

Group type: EXPERIMENTAL
Intervention: 600 mg tiaprofenic acid per day, in 3 divided doses
Number of subjects: 80

Group type: COMPARATOR
Intervention: 75 mg indomethacin per day, in 3 divided doses
Number of subjects: 80
Study: 30854006

Group type: EXPERIMENTAL
Intervention: Herbal toothpaste containing Rhizoma Chuanxiong and Rhizoma Imperatae extracts
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 120
Study: 28236511

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 308
Study: 26188490

Group type: EXPERIMENTAL
Intervention: Preventive nutritional support
Number of subjects: 53

Group type: COMPARATOR
Intervention: On demand nutritional support
Number of subjects: 53
Study: 24477179

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study: 22066827

Group type: EXPERIMENTAL
Intervention: PPE (9 capsules/day) as adjunctive therapy combined with HRT
Number of subjects: 48

Group type: COMPARATOR
Intervention: Calcium (260 mg/day) as adjunctive therapy combined with HRT
Number of subjects: 48